Qiagen Acquires Genoox For $70 Million Plus $10 Million In Milestones

Reuters
13 May
May 12 (Reuters) - Qiagen NV ::
*QIAGEN ENHANCES LEADING CLINICAL GENOMICS PORTFOLIO WITH ACQUISITION OF GENOOX AI-POWERED SOFTWARE
*QIAGEN NV - ACQUISITION IS EXPECTED TO GENERATE APPROXIMATELY $5 MLN OF SALES IN 2025 FOR QIAGEN AND HAVE A NEUTRAL IMPACT ON ADJUSTED EPS
*QIAGEN NV - ACQUIRES GENOOX FOR $70 MILLION PLUS $10 MILLION IN MILESTONES

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 12-MAY-202520:05:00.243 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10